STEP:

SPLASH™ Technology Enablement Program

Your biomarker. Your protocol. Your lab.

STEP is a comprehensive program that enables scientists to develop, validate, and deploy custom ultrasensitive protein biomarker assays using the Taudia SPLASH platform -- all on the qPCR systems and infrastructure.

The Challenge:

Traditional assay development often requires specialized instrumentation, complex workflows, and rigid protocols, which lead to:

  • Long assay development timelines
  • Limited flexibility to optimize for specific targets
  • Difficulty scaling from discovery to clinical
  • Expensive proprietary instrumentation
Purple qPCR illustration with colored lines to represent results on the device screen.

SPLASH delivers ultrasensitive protein quantitation on any qPCR instrument.

Simplify custom development with STEP

STEP empowers your laboratory to build and run custom ultrasensitive assays independently. This enables faster biomarker development, greater flexibility, and long-term cost efficiencies.

ACCELERATE

Reduce timelines with SPLASH technology

DEVELOP

Custom workflows for your biomarkers

SCALE

Seamlessly transition to routine use

EMPOWER

Proven workflow and ongoing support

Success through partnership

Taudia scientists partner with your team every step of the way to ensure a smooth transition and sustainable in-house assay development capabilities.
Let’s talk